Polymyxin B sulfate: Difference between revisions
Jump to navigation
Jump to search
Undo revision 927065 by Mohamed Moubarak (talk) |
|||
| Line 13: | Line 13: | ||
'''[[Polymyxin B sulfate description|Description]]''' | '''[[Polymyxin B sulfate description|Description]]''' | ||
'''| [[Polymyxin B sulfate clinical pharmacology|Clinical Pharmacology]]''' | '''| [[Polymyxin B sulfate clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[Polymyxin B sulfate microbiology|Microbiology]]''' | |||
'''| [[Polymyxin B sulfate indications and usage|Indications and Usage]]''' | '''| [[Polymyxin B sulfate indications and usage|Indications and Usage]]''' | ||
'''| [[Polymyxin B sulfate contraindications|Contraindications]]''' | '''| [[Polymyxin B sulfate contraindications|Contraindications]]''' | ||
'''| [[Polymyxin B sulfate warnings and precautions|Warnings and Precautions]]''' | '''| [[Polymyxin B sulfate warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[Polymyxin B sulfate adverse reactions|Adverse Reactions]]''' | '''| [[Polymyxin B sulfate adverse reactions|Adverse Reactions]]''' | ||
'''| [[Polymyxin B sulfate drug interactions|Drug Interactions]]''' | |||
'''| [[Polymyxin B sulfate overdosage|Overdosage]]''' | |||
'''| [[Polymyxin B sulfate dosage and administration|Dosage and Administration]]''' | '''| [[Polymyxin B sulfate dosage and administration|Dosage and Administration]]''' | ||
'''| [[Polymyxin B sulfate how supplied|How Supplied]]''' | '''| [[Polymyxin B sulfate how supplied|How Supplied]]''' | ||
Revision as of 03:29, 7 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Category
US Brand Names
NEOSPORIN®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Dosage and Administration | How Supplied